Nilotinib EP Impurity D
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

641569-94-0Nilotinib EP Impurity D

● 在庫あり

カタログ番号:VE006047
CAS番号:641569-94-0
分子式:C17H14N4O2
分子量:306.33

に関する追加情報 CAS 641569-94-0

親薬物

Nilotinib

IUPAC名

4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid

薬局方同義語

N/A

Other Synonyms

Nilotinib Carboxylic Acid Impurity

SMILES

O=C(O)C1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1

InChI

InChI=1S/C17H14N4O2/c1-11-4-5-12(16(22)23)9-15(11)21-17-19-8-6-14(20-17)13-3-2-7-18-10-13/h2-10H,1H3,(H,22,23)(H,19,20,21)

説明

Nilotinib EP Impurity D, also known as Nilotinib Carboxylic Acid Impurity is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Nilotinib. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications. Also known as Nilotinib Carboxylic Acid Impurity, it is an impurity present in Nilotinib is a synthetic amino pyrimidine, a second-generation tyrosine kinase inhibitor used for the treatment of imatinib-resistant chronic myelogenous leukemia in the form of nilotinib hydrochloride monohydrate salt.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url